• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较原代人肝细胞和肝癌细胞系,以模拟脂肪酸、果糖和葡萄糖对肝细胞脂质积累的影响。

A Comparison of Primary Human Hepatocytes and Hepatoma Cell Lines to Model the Effects of Fatty Acids, Fructose and Glucose on Liver Cell Lipid Accumulation.

机构信息

Division of Food, Nutrition and Dietetics, School of Biosciences, Sutton Bonington Campus, University of Nottingham, Loughborough LE12 5RD, Leicestershire, UK.

Fund for the Replacement of Animals in Medical Experiments (FRAME) Laboratory, School of Life Sciences, University of Nottingham, Nottingham NG7 2UH, Nottinghamshire, UK.

出版信息

Nutrients. 2022 Dec 21;15(1):40. doi: 10.3390/nu15010040.

DOI:10.3390/nu15010040
PMID:36615698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9824391/
Abstract

Non-alcoholic fatty liver disease (NAFLD) begins with lipid accumulation within hepatocytes, but the relative contributions of different macronutrients is still unclear. We investigated the impact of fatty acids, glucose and fructose on lipid accumulation in primary human hepatocytes (PHH) and three different cell lines: HepG2 (human hepatoblastoma−derived cell line), Huh7 (human hepatocellular carcinoma cell line) and McA-RH7777 (McA, rat hepatocellular carcinoma cell line). Cells were treated for 48 h with fatty acids (0 or 200 μM), glucose (5 mM or 11 mM) and fructose (0 mM, 2 mM or 8 mM). Lipid accumulation was measured via Nile Red staining. All cell types accumulated lipid in response to fatty acids (p < 0.001). PHH and McA, but not HepG2 or Huh7 cells, accumulated more lipid with 11 mM glucose plus fatty acids (p = 0.004, fatty acid × glucose interaction, for both), but only PHH increased lipid accumulation in response to fructose (p < 0.001). Considerable variation was observed between PHH cells from different individuals. Lipid accumulation in PHH was increased by insulin (p = 0.003) with inter-individual variability. Similarly, insulin increased lipid accumulation in both HepG2 and McA cells, with a bigger response in McA in the presence of fatty acids (p < 0.001 for fatty acid × insulin). McA were more insulin sensitive than either HepG2 or Huh7 cells in terms of AKT phosphorylation (p < 0.001 insulin × cell type interaction). Hence, glucose and fructose can contribute to the accumulation of lipid in PHH with considerable inter-individual variation, but hepatoma cell lines are not good models of PHH.

摘要

非酒精性脂肪性肝病 (NAFLD) 始于肝细胞内脂质堆积,但不同宏量营养素的相对贡献仍不清楚。我们研究了脂肪酸、葡萄糖和果糖对原代人肝细胞 (PHH) 和三种不同细胞系(HepG2 [人肝癌衍生细胞系]、Huh7 [人肝癌细胞系]和 McA-RH7777 [McA,大鼠肝癌细胞系])中脂质堆积的影响。细胞用脂肪酸(0 或 200 μM)、葡萄糖(5 mM 或 11 mM)和果糖(0 mM、2 mM 或 8 mM)处理 48 h。通过尼罗红染色测量脂质堆积。所有细胞类型在脂肪酸作用下都堆积了脂质(p < 0.001)。PHH 和 McA,但不是 HepG2 或 Huh7 细胞,在用 11 mM 葡萄糖加脂肪酸处理时堆积了更多的脂质(p = 0.004,脂肪酸×葡萄糖相互作用,两者均),但只有 PHH 对果糖有反应增加了脂质堆积(p < 0.001)。不同个体的 PHH 细胞之间存在相当大的差异。胰岛素(p = 0.003)增加了 PHH 中的脂质堆积,个体间存在差异。同样,胰岛素增加了 HepG2 和 McA 细胞中的脂质堆积,在存在脂肪酸时,McA 的反应更大(脂肪酸×胰岛素,p < 0.001)。在 AKT 磷酸化方面,McA 比 HepG2 或 Huh7 细胞更敏感胰岛素(p < 0.001 胰岛素×细胞类型相互作用)。因此,葡萄糖和果糖可以导致 PHH 中脂质堆积,个体间差异较大,但肝癌细胞系不是 PHH 的良好模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06cc/9824391/04a51f11afd0/nutrients-15-00040-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06cc/9824391/e5ceeda61f3d/nutrients-15-00040-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06cc/9824391/cfa4b935a543/nutrients-15-00040-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06cc/9824391/45a98926fec1/nutrients-15-00040-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06cc/9824391/04a51f11afd0/nutrients-15-00040-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06cc/9824391/e5ceeda61f3d/nutrients-15-00040-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06cc/9824391/cfa4b935a543/nutrients-15-00040-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06cc/9824391/45a98926fec1/nutrients-15-00040-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06cc/9824391/04a51f11afd0/nutrients-15-00040-g004.jpg

相似文献

1
A Comparison of Primary Human Hepatocytes and Hepatoma Cell Lines to Model the Effects of Fatty Acids, Fructose and Glucose on Liver Cell Lipid Accumulation.比较原代人肝细胞和肝癌细胞系,以模拟脂肪酸、果糖和葡萄糖对肝细胞脂质积累的影响。
Nutrients. 2022 Dec 21;15(1):40. doi: 10.3390/nu15010040.
2
Characterization of lipid metabolism in a novel immortalized human hepatocyte cell line.一种新型永生化人肝细胞系中脂质代谢的特征分析。
Am J Physiol Endocrinol Metab. 2015 Sep 15;309(6):E511-22. doi: 10.1152/ajpendo.00594.2014. Epub 2015 Jun 30.
3
Exploratory Data Analysis of Cell and Mitochondrial High-Fat, High-Sugar Toxicity on Human HepG2 Cells.细胞和线粒体高脂高糖毒性对人 HepG2 细胞的探索性数据分析。
Nutrients. 2021 May 19;13(5):1723. doi: 10.3390/nu13051723.
4
Biomechanics of cultured hepatic cells during different steatogenic hits.培养肝细胞在不同成脂刺激下的生物力学特性。
J Mech Behav Biomed Mater. 2019 Sep;97:296-305. doi: 10.1016/j.jmbbm.2019.05.036. Epub 2019 May 22.
5
Differential capability of metabolic substrates to promote hepatocellular lipid accumulation.代谢底物促进肝细胞脂质积累的差异能力。
Eur J Nutr. 2019 Dec;58(8):3023-3034. doi: 10.1007/s00394-018-1847-2. Epub 2018 Oct 27.
6
Glucose and fatty acid metabolism in McA-RH7777 hepatoma cells vs. rat primary hepatocytes: responsiveness to nutrient availability.McA-RH7777肝癌细胞与大鼠原代肝细胞中的葡萄糖和脂肪酸代谢:对营养物质可利用性的反应性
Biochim Biophys Acta. 2004 Aug 30;1684(1-3):54-62. doi: 10.1016/j.bbalip.2004.06.005.
7
Effect of fructose and 3,5-diiodothyronine (3,5-T(2)) on lipid accumulation and insulin signalling in non-alcoholic fatty liver disease (NAFLD)-like rat primary hepatocytes.果糖和3,5-二碘甲腺原氨酸(3,5-T(2))对非酒精性脂肪性肝病(NAFLD)样大鼠原代肝细胞脂质积累和胰岛素信号传导的影响。
Horm Metab Res. 2014 May;46(5):333-40. doi: 10.1055/s-0034-1371858. Epub 2014 May 9.
8
Gryllus bimaculatus De Geer hydrolysates alleviate lipid accumulation, inflammation, and endoplasmic reticulum stress in palmitic acid-treated human hepatoma G2 cells.直翅目蟋蟀水解物可减轻棕榈酸处理的人肝癌 G2 细胞中的脂质积累、炎症和内质网应激。
J Ethnopharmacol. 2022 Jun 12;291:115117. doi: 10.1016/j.jep.2022.115117. Epub 2022 Feb 17.
9
Differences in glycolytic capacity and hypoxia tolerance between hepatoma cells and hepatocytes.肝癌细胞与肝细胞之间糖酵解能力和缺氧耐受性的差异。
Hepatology. 1991 Feb;13(2):297-303.
10
Chemerin causes lipid metabolic imbalance and induces passive lipid accumulation in human hepatoma cell line via the receptor GPR1.Chemerin 通过受体 GPR1 引起脂质代谢失衡,并诱导人肝癌细胞系中的被动脂质积累。
Life Sci. 2021 Aug 1;278:119530. doi: 10.1016/j.lfs.2021.119530. Epub 2021 Apr 20.

引用本文的文献

1
Hepatic Lipoprotein Metabolism: Current and Future In Vitro Cell-Based Systems.肝脏脂蛋白代谢:当前和未来基于细胞的体外系统
Biomolecules. 2025 Jul 2;15(7):956. doi: 10.3390/biom15070956.
2
Crosstalk Between Dietary Fatty Acids and MicroRNAs in the Regulation of Hepatic ApoB-Containing Lipoprotein Synthesis in Humans.膳食脂肪酸与微小RNA在人类肝脏含载脂蛋白B脂蛋白合成调控中的相互作用
Int J Mol Sci. 2025 May 17;26(10):4817. doi: 10.3390/ijms26104817.
3
Experimental Models to Investigate PNPLA3 in Liver Steatosis.用于研究PNPLA3在肝脂肪变性中作用的实验模型。

本文引用的文献

1
Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review.非酒精性脂肪性肝病和代谢综合征中添加果糖:叙述性综述。
Nutrients. 2022 Mar 8;14(6):1127. doi: 10.3390/nu14061127.
2
Fructose and the Liver.果糖与肝脏。
Int J Mol Sci. 2021 Jun 28;22(13):6969. doi: 10.3390/ijms22136969.
3
A Systematic Review of Animal Models of NAFLD Finds High-Fat, High-Fructose Diets Most Closely Resemble Human NAFLD.一项非酒精性脂肪性肝病动物模型的系统评价发现,高脂肪、高果糖饮食最接近人类非酒精性脂肪性肝病。
Liver Int. 2025 May;45(5):e70091. doi: 10.1111/liv.70091.
4
Cell Homeostasis or Cell Death-The Balancing Act Between Autophagy and Apoptosis Caused by Steatosis-Induced Endoplasmic Reticulum (ER) Stress.细胞稳态或细胞死亡——脂肪变性诱导的内质网(ER)应激引起的自噬与凋亡之间的平衡行为
Cells. 2025 Mar 18;14(6):449. doi: 10.3390/cells14060449.
5
Sexually Dimorphic Effects of CYP2B6 in the Development of Fasting-Mediated Steatosis in Mice: Role of the Oxylipin Products 9-HODE and 9-HOTrE.CYP2B6在小鼠禁食介导的脂肪变性发展中的性别二态性效应:氧化脂质产物9-羟基十八碳二烯酸(9-HODE)和9-羟基十八碳三烯酸(9-HOTrE)的作用
Biomedicines. 2025 Jan 25;13(2):295. doi: 10.3390/biomedicines13020295.
6
Dietary fat quantity and composition influence hepatic lipid metabolism and metabolic disease risk in humans.膳食脂肪的数量和组成会影响人体的肝脏脂质代谢及代谢疾病风险。
Dis Model Mech. 2025 Jan 1;18(1). doi: 10.1242/dmm.050878. Epub 2025 Jan 29.
7
Fanlian Huazhuo Formula: A promising herbal preparation for metabolic liver disease.矾连化浊方:一种用于代谢性肝病的有前景的草药制剂。
World J Gastroenterol. 2024 Dec 14;30(46):4964-4968. doi: 10.3748/wjg.v30.i46.4964.
8
Subcellular expression of CYP2E1 in HepG2 cells impacts response to free oleic and palmitic acid.CYP2E1在HepG2细胞中的亚细胞表达影响对游离油酸和棕榈酸的反应。
Curr Res Toxicol. 2024 Sep 28;7:100195. doi: 10.1016/j.crtox.2024.100195. eCollection 2024.
9
Protein kinase D2 modulates hepatic insulin sensitivity in male mice.蛋白激酶 D2 调节雄性小鼠肝脏胰岛素敏感性。
Mol Metab. 2024 Dec;90:102045. doi: 10.1016/j.molmet.2024.102045. Epub 2024 Oct 12.
10
Time-course characterization of whole-transcriptome dynamics of HepG2/C3A spheroids and its toxicological implications.HepG2/C3A 球体全转录组动态的时程特征及其毒理学意义。
Toxicol Lett. 2024 Nov;401:125-138. doi: 10.1016/j.toxlet.2024.10.004. Epub 2024 Oct 3.
Hepatology. 2021 Oct;74(4):1884-1901. doi: 10.1002/hep.31897. Epub 2021 Jun 17.
4
The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights.果糖在非酒精性脂肪性肝炎中的作用:旧关系和新见解。
Nutrients. 2021 Apr 16;13(4):1314. doi: 10.3390/nu13041314.
5
Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development.非酒精性脂肪性肝病(NAFLD)概述以及含糖食物消费和其他饮食成分在其发展中的作用。
Nutrients. 2021 Apr 24;13(5):1442. doi: 10.3390/nu13051442.
6
Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial.果糖和蔗糖饮料而非葡萄糖饮料会促进肝脏从头合成脂肪:一项随机对照试验。
J Hepatol. 2021 Jul;75(1):46-54. doi: 10.1016/j.jhep.2021.02.027. Epub 2021 Mar 6.
7
A hexokinase isoenzyme switch in human liver cancer cells promotes lipogenesis and enhances innate immunity.肝癌细胞中己糖激酶同工酶的转换促进脂肪生成并增强先天免疫。
Commun Biol. 2021 Feb 16;4(1):217. doi: 10.1038/s42003-021-01749-3.
8
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview.非酒精性脂肪性肝病的病理生理学、分子和治疗问题概述。
Int J Mol Sci. 2019 Apr 20;20(8):1948. doi: 10.3390/ijms20081948.
9
The role of dietary sugars in health: molecular composition or just calories?饮食糖在健康中的作用:是分子组成还是仅仅是卡路里?
Eur J Clin Nutr. 2019 Sep;73(9):1216-1223. doi: 10.1038/s41430-019-0407-z. Epub 2019 Feb 20.
10
Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease.脂质负荷人肝细胞培养的基因组学可用于筛选治疗非酒精性脂肪性肝病的药物靶点。
BMC Med Genomics. 2018 Dec 14;11(1):111. doi: 10.1186/s12920-018-0438-7.